Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yasuo TESHIMA"'
Autor:
Hiroyuki Eguchi, Junichi Tani, Saori Hirao, Munehisa Tsuruta, Ichiro Tokubuchi, Kentaro Yamada, Masataka Kasaoka, Yasuo Teshima, Tatsuyuki Kakuma, Yuji Hiromatsu
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
Intravenous methylprednisolone (IVMP) pulse therapy is the first-line treatment for the active phase of moderate to severe Graves’ orbitopathy (GO). However, acute and severe liver damage has been reported during and after IVMP therapy. In this ret
Externí odkaz:
https://doaj.org/article/0d21001d2726488da1dae146b062de84
Autor:
Shiho Watanabe, Naohiro Araki, Tamotsu Kato, Yuko Matsuo, Yuji Hiromatsu, Hiroyuki Eguchi, Yasuo Teshima, Junichi Tani
Publikováno v:
Endocrine Journal. 67:347-352
Graves' ophthalmopathy (GO) is characterized by an autoimmune reaction against thyrotropin (TSH) receptors and is diagnosed by TSH receptor antibody (TRAb). A novel assay for thyroid-stimulating antibody (TSAb) was recently introduced using a frozen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19874b2da2f1c0fb73110450bad431bc
https://doi.org/10.1507/endocrj.ej19-0398
https://doi.org/10.1507/endocrj.ej19-0398
Autor:
Munehisa Tsuruta, Yasuo Teshima, Tatsuyuki Kakuma, Saori Hirao, Junichi Tani, Kentaro Yamada, Ichiro Tokubuchi, Masataka Kasaoka, Hiroyuki Eguchi, Yuji Hiromatsu
Publikováno v:
International Journal of Endocrinology
International Journal of Endocrinology, Vol 2015 (2015)
International Journal of Endocrinology, Vol 2015 (2015)
Intravenous methylprednisolone (IVMP) pulse therapy is the first-line treatment for the active phase of moderate to severe Graves’ orbitopathy (GO). However, acute and severe liver damage has been reported during and after IVMP therapy. In this ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d371a96e756f14c11df2ca30be4cfa7d
https://doi.org/10.1155/2015/835979
https://doi.org/10.1155/2015/835979
Role of a new bioassay for thyroid-stimulating antibodies (aequorin TSAb) in Graves' ophthalmopathy.
Autor:
Yuji Hiromatsu, Hiroyuki Eguchi, Yuko Matsuo, Tamotsu Kato, Junichi Tani, Shiho Watanabe, Yasuo Teshima, Naohiro Araki
Publikováno v:
Endocrine Journal; 2020, Vol. 67 Issue 3, p347-352, 6p
Publikováno v:
Internal medicine (Tokyo, Japan). 53(5)
Graves' ophthalmopathy (GO) is an autoimmune disorder of the orbit that is clinically relevant in 25-50% of patients with Graves' disease and 2% of patients with chronic thyroiditis. The age-adjusted annual incidence of clinically relevant GO is 16 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88390d59123ca07142556906462d9b63
https://pubmed.ncbi.nlm.nih.gov/24583420
https://pubmed.ncbi.nlm.nih.gov/24583420
Autor:
Yukiko MIZUTA, Hiroyasu IJYUIN, Satoshi ITANO, Naofumi ONO, Ryukichi KUMASHIRO, Michio SATA, Yutaka NAKASHIMA, Osamu NAKASHIMA, Yasuo TESHIMA
Publikováno v:
Kanzo. 42:664-668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e24c1612f24e546049b7b1d823ff1d4d
https://doi.org/10.2957/kanzo.42.664
https://doi.org/10.2957/kanzo.42.664
Autor:
Eiko Ikeda, Masaharu Sakamoto, Hiroshi Yoshida, Hiroyuki Koga, Shotaro Sakisaka, Yasuo Teshima, Michio Sata, Kyuichi Tanikawa, Masaru Harada, Keiichi Mitsuyama, Matsuo Katsuhiko
Publikováno v:
Scandinavian journal of rheumatology. 27(1)
The aortitis syndrome is a chronic inflammatory process that affects the aorta and its primary branches. Patients with aortitis syndrome exhibit various ocular changes. We present a patient in whom cataract was the initial objective finding. The seru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c78f40833b83a8f2ce17919dbe966b9e
https://pubmed.ncbi.nlm.nih.gov/9506883
https://pubmed.ncbi.nlm.nih.gov/9506883
Publikováno v:
Scandinavian Journal of Rheumatology; 1998, Vol. 27 Issue 1, p78-79, 2p